BRL 42852ER; 9(S)-Erythromycylamine; LY024410
26116-56-3
735
C37H70N2O12
DMF, DMSO, Ethanol
-20°C
Erythromycylamine is a semi-synthetic analogue of erythromycin prepared by reduction of erythromycin oxime. Erythromycylamine is a potent antibiotic, however the introduction of the amino- moiety increases the compound's polarity and is disadvantageous for in vivo use. This limitation was overcome by the synthesis of dirithromycin, a Schiff base pro-drug that dissociates in vivo to erythromycylamine.
0.1 lbs
Research or further manufacturing use only, not for food or drug use.
